After US Victory, Breast Cancer Patients Take The Anti-Gene Patent Fight To Australia
from the don't-patent-our-DNA dept
The difference here may be that, in Australia, Myriad worked out a deal with a local company, and that company has "gifted" the patent to various healthcare institutions for no royalty, meaning that the fact pattern is a bit different (in the US, if you wanted the test, you had to go to Myriad... or... Myriad). Of course, last year we had mentioned that Australian politicians were already discussing the possibility of outlawing gene patents -- so, potentially the regulatory process could make the judicial process here moot.